Synaptogenix is a New York-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of neurodegenerative disorders.
Business Model:
Revenue: $0
Employees: 2-10
Address: 1185 Avenue of the Americas
City: New York
State: NY
Zip: 10036
Country: US
Synaptogenix is a New York-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of neurodegenerative disorders.
Contact Phone:
+19732420005
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
12/18/2020
Ticker Symbol:
SNPX
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2013 | Equity | $11.5M | 11/2022 | Post-IPO Equity | $15M | 1/2021 | Private Placement | $14M | 2/2013 | Equity | $9.1M | 6/2021 | Post-IPO Equity | $12.5M | 1/2021 | Post-IPO Equity | $14M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|